Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Kisner Insider Profile
4 Followers
Daniel Kisner, Director at Dynavax, holds 17.57K shares in Dynavax (Ticker: DVAX), holds 0.00 shares in Zynerba Pharmaceuticals (Ticker: ZYNE), holds 10.00K shares in Oncternal Therapeutics (Ticker: ONCT).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+10.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Daniel Kisner holds in companies
Most Profitable Insider Trade
Stock:
Oncternal Therapeutics
(ONCT)
(ONCT)
Rating:Informative Buy
Date:Jul 23, 2020 - Jul 23, 2021
Return:+68.00%
The most profitable trade made by Daniel Kisner
Daniel Kisner's Trading History
Dynavax
May 28, 2024
Director
Uninformative Buy
―
$223.50K
Zynerba Pharmaceuticals
Oct 11, 2023
―
Uninformative Sell
―
$0.00
Oncternal Therapeutics
Jul 23, 2020
―
Informative Buy
23.80K
$5.26K
Arbutus Biopharma
Dec 31, 2014
Former Director
Uninformative Buy
―
$40.13K
Histogen
Dec 30, 2016
Director
Uninformative Buy
―
$192.91
Apollo Endosurgery
Jul 31, 2012
―
Uninformative Buy
―
$705.90K
List of latest transactions for each holding click on a transaction to see Daniel Kisner's performance on stock
You May Also Like
Daniel Kisner insider profile FAQ
What is the percentage of profitable transactions made by Daniel Kisner?
The percentage of profitable transactions made by Daniel Kisner is 50%.
What is the average return per transaction made by Daniel Kisner?
The average return per transaction made by Daniel Kisner is 10.10%.
What stocks does Daniel Kisner hold?
Daniel Kisner holds: DVAX, ZYNE, ONCT, ABUS, HSTOQ, APEN stocks.
What was Daniel Kisner’s latest transaction?
Daniel Kisner latest transaction was an Uninformative Buy of ―.
What was Daniel Kisner's most profitable transaction?
Daniel Kisner’s most profitable transaction was an Informative Buy of ONCT stock on July 23, 2020. The return on the trade was 68.00%.
What is Daniel Kisner's role in Dynavax?
Daniel Kisner's role in Dynavax is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.